← FDA DRUG APPROVALS
FDA ANDA · ANDA218386
ALBUTEROL SULFATE INHALATION SOLUTION, 0.5%
albuterol sulfate
Sponsor: RITEDOSE CORP
APPLICATION
ANDA218386
TYPE
ANDA
ORIGINAL APPROVAL
2025-03-12
LATEST ACTION
2025-03-12
ROUTE
RESPIRATORY (INHALATION), INHALATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
ALBUTEROL SULFATEPrescription
ALBUTEROL SULFATE EQ 0.5% BASE · SOLUTION · INHALATION
Approval history
2025-03-12UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.